SMO and mesothelioma: This study evaluated the factors affecting the development of malignant mesothelioma, proposed a new idea of SMO, GLI1, and immune cells as possible indicators of personalized immunotherapy and prognosis, and provided an experimental basis for finding new gene targets for mesothelioma.